Pneumologie 2007

Was ist neu?

• Asthma bronchiale: neue Leitlinien, Antibiotika, Deeskalation der Therapie

• COPD: Prognoseabschätzung, Roflumilast, TORCH-Studie

• Lungengerüsterkrankungen: Verlaufsabschätzung, positive Effekte von Cyclophosphamid

• Schlafbezogene Atemstörungen: Zusammenhang mit Schlaganfall?

• Lungenembolie: Wann lysieren?

• Pulmonale Hypertonie und Bewegung

• Bronchialkarzinom: Platin von Vorteil.

• Pneumonie: Wie einschätzen, wann Therapie beginnen?

• Intensivmedizin: Probleme beim Weaning

Literatur

• 1 Arzt M, Young T, Finn L. et al . Association of sleep-disordered breathing and the occurrence of stroke.  Am J Respir Crit Care Med. 2005;  11 1447-1451
• 2 Bateman E D, Jacques L, Goldfrad C. et al . Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down.  J Allergy Clin Immunol. 2006;  3 563-570
• 3 Bauer T T, Ewig S, Marre R. et al . CRB-65 predicts death from community-acquired pneumonia.  J Intern Med. 2006;  1 93-101
• 4 Binder L, Pieske B, Olschewski M. et al . N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism.  Circulation. 2005;  11 1573-1579
• 5 Calverley P M, Anderson J A, Celli B. et al . Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.  N Engl J Med. 2007;  8 775-789
• 6 Capelastegui A, Espana P P, Quintana J M. et al . Validation of a predictive rule for the management of community-acquired pneumonia.  Eur Respir J. 2006;  1 151-157
• 7 Francois B, Bellissant E. et al . 12-h pretreatment with methylprednisolone versus placebo for prevention of postextubation laryngeal oedema: a randomised double-blind trial.  Lancet. 2007;  9567 1083-1089
• 8 Hotta K, Matsuo K, Ueoka H. et al . Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer.  J Clin Oncol. 2004;  19 3852-3859
• 9 Huang C J, Lin H C. Association between adrenal insufficiency and ventilator weaning.  Am J Respir Crit Care Med. 2006;  3 276-280
• 10 Jegal Y, Kim D S, Shim T S. et al . Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia.  Am J Respir Crit Care Med. 2005;  6 639-644
• 11 Johnston S L, Blasi F, Black P N, Martin R J, Farrell D J, Nieman R B. The effect of telithromycin in acute exacerbations of asthma.  N Engl J Med. 2006;  15 1589-1600
• 12 Kumar A, Roberts D, Wood K E. et al . Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.  Crit Care Med. 2006;  6 1589-1596
• 13 Mereles D, Ehlken N. et al . Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension.  Circulation. 2006;  14 1482-1489
• 14 Munoz R, Duran-Cantolla J. et al . Severe sleep apnea and risk of ischemic stroke in the elderly.  Stroke. 2006;  9 2317-2321
• 15 Rabe K F, Bateman E D, O’Donnell D. et al . Roflumilast-an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial.  Lancet. 2005;  9485 563-571
• 16 Takigawa N, Tada A, Soda R. et al . Distance and oxygen desaturation in 6-min walk test predict prognosis in COPD patients.  Respir Med. 2007;  3 561-567
• 17 Tashkin D P, Elashoff R, Clements P J. et al . Cyclophosphamide versus placebo in scleroderma lung disease.  N Engl J Med. 2006;  25 2655-2666